Immunotherapy Clinical Trials

Immunotherapy Integrated Research Center (IIRC)

Immunotherapy Clinical Trials

Stan Collender receives an infusion of the immunotherapy drug pembrolizumab from Karen Haeck, RN., at Seattle Cancer Care Alliance. Collender is taking part in a national trial of the drug, led by Fred Hutch investigators, for patients with advanced Merkel cell carcinoma, a rare skin cancer.

Photo by Robert Hood / Fred Hutch News Service

First-of-its-kind immunotherapy clinic for patients

Fred Hutch has immunotherapy clinical trials open for a variety of cancers. Patients enrolled on a trial will be seen in the Bezos Family Immunotherapy Clinic at Seattle Cancer Care Alliance, the Hutch's clinical care partner.

This first-of-its-kind clinic is dedicated to providing innovative immunotherapies to patients in clinical trials. The clinic doubles the previous capacity for enrolling patients on trials of the Hutch's novel immunotherapies and enables more intensive monitoring of patients to better understand why some respond to a therapy while others do not. It features patient care suites to accommodate a wide array of outpatient services as well as space for family and friends to accompany patients.

Dr. David Maloney, medical director of cellular immunotherapy at the Hutch and the clinic, oversees research and patient care at the clinic. The clinic has a team-based model of care tailored for immunotherapy patients’ unique needs and is staffed by physician-scientists who are experts in these emerging therapies.

The list of a number if immunotherapy clinical trials below is constantly evolving.  Visit Fred Hutch's clinical trials page for more trials.
 

Lymphoma

        View all lymphoma clinical trials